(February 26, 2019) Ovarian Cancer Research Alliance is pleased to announce Beth Y. Karlan, M.D as our new chair of OCRA’s Scientific Advisory Committee. Our Scientific Advisory Committee is comprised of 24 illustrious and respected leaders in research on treating women with ovarian cancer.
Dr. Karlan is Professor and Vice Chair of Women’s Health Research in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine, University of California Los Angeles (UCLA). She is also Director of Cancer Population Genetics at the Jonsson Comprehensive Cancer Center at UCLA. Dr. Karlan’s research focuses on ovarian and other women’s cancers as well as inherited cancer susceptibility. She has authored over 300 research publications and is an American Cancer Society Clinical Research Professor. She is the Editor-in-Chief of the scientific journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Dr. Karlan was appointed by the White House to serve on the National Cancer Advisory Board and in 2015 she was elected to membership in the National Academy of Medicine. In 2018, Dr. Karlan was named a Fellow of the American Society of Clinical Oncology.
“I am excited to take on this role and provide scientific guidance to one of the most influential and effective private funding sources supporting ovarian cancer research. I look forward to working with OCRA’s leadership to grow its legacy of investing in innovative research that is leading us to new approaches to diagnose, treat and even prevent ovarian cancer.” Beth Y. Karlan, M.D., OCRA SAC Chair
“With Dr. Beth Karlan leading our Scientific Advisory Committee, OCRA is poised to take its leadership role in ovarian cancer grantmaking to a new level. We are honored to be working alongside Dr. Karlan in the quest to end this disease.” Audra Moran, President and CEO, OCRA
